Compare Canadian Pacific Kansas City Limited Common Shares (CP) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Canadian Pacific Kansas City Limited Common Shares vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Canadian Pacific Kansas City Limited Common Shares trades at $83.86 (market cap $73.71B), while Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B). The key difference: Canadian Pacific Kansas City Limited Common Shares is far larger — about 43.1× Nuvation Bio Inc. Class A Common Stock's market cap, and Canadian Pacific Kansas City Limited Common Shares pays a 0.91% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals.
| CP | NUVB | |
|---|---|---|
Market Cap | $73.71B | $1.71B |
Volume | 2,143,178 | 5,448,712 |
Sector | Industrials | Health |
52-Week High | $96.69 | $9.54 |
52-Week Low | $68.88 | $3.41 |
Enterprise Value | $91.14B | $1.30B |
Dividend Yield | 0.91% | — |
Typical Hold Time | — | 0 Days |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Canadian Pacific Kansas City Limited Common Shares
Canadian Pacific Kansas City operates a freight railway connecting Canada, the United States, and Mexico. The company was formed through the combination of Canadian Pacific and Kansas City Southern.
Read more on CP →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
